CDSCO
- Status: likely_approved
🇮🇳 Huluc63 in India
Huluc63 (elotuzumab) regulatory status in India.
Marketing authorisation
Huluc63 in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in India
Frequently asked questions
Is Huluc63 approved in India?
Yes. CDSCO has authorised it.
Who is the marketing authorisation holder for Huluc63 in India?
Bristol-Myers Squibb is the originator. The local marketing authorisation holder may differ — check the official source linked above.